#$%^&*AU2020203936A120200702.pdf#####Abstract The invention relates novel pharmaceutical use of isosteviol in treating and preventing cardiac fibrosis remodeling by modulating production of cGMP or cAMP or their isomers, and/or by reducing reactive oxygen species (ROS). 1